{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T03:21:04Z","timestamp":1794280864620,"version":"4.9.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T00:00:00Z","timestamp":1771200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T00:00:00Z","timestamp":1774396800000},"content-version":"vor","delay-in-days":37,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2024M753319"],"award-info":[{"award-number":["2024M753319"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Postdoctoral Fellowship Program of CPSF","award":["GZC20232777"],"award-info":[{"award-number":["GZC20232777"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82404504"],"award-info":[{"award-number":["82404504"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012547","name":"Natural Science Foundation of Guangxi Zhuang Autonomous Region","doi-asserted-by":"publisher","award":["2025GXNSFAA069334"],"award-info":[{"award-number":["2025GXNSFAA069334"]}],"id":[{"id":"10.13039\/100012547","id-type":"DOI","asserted-by":"publisher"}]},{"name":"visiting Scholar Program of Bagui","award":["Xueni Wang"],"award-info":[{"award-number":["Xueni Wang"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Commun Signal"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Prostate cancer, a leading cause of cancer-related mortality in men, often develops resistance to conventional therapies, necessitating the discovery of novel therapeutic targets. Catalase plays a critical role in maintaining cellular redox homeostasis. Its inhibition disrupts oxidative balance, leading to oxidative stress and cell death, which positions catalase as a promising therapeutic target for cancer treatment. This study explores the anti-cancer effects and mechanisms of action of trichodermamide B in targeting catalase-induced apoptosis in prostate cancer cells.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The anti-prostate cancer activity of trichodermamide B was evaluated using multiple prostate cancer cell lines, including LNCaP, 22Rv1, PC-3, and DU145. Cytotoxicity was assessed through cell viability assays, while clonogenic assays were employed to measure the compound's ability to inhibit colony formation. The impact on 3D cell sphere growth was examined using LNCaP-3D models. Flow cytometry was utilized to analyze cell cycle arrest and apoptosis induction. Molecular docking studies were conducted to predict the interaction between trichodermamide B and catalase. The cell-free catalase enzymatic activity assay was employed to detect the inhibitory effect of trichodermamide B on catalase activity in vitro. Proteome profiler human apoptosis array kits and immunoblotting were used to validate the suppression of catalase expression. Additionally, the effects on androgen receptor (AR) activity and AR target genes (KLK3 and TMPRSS2) were investigated by western blot and qPCR. In vivo efficacy was confirmed using zebrafish and mouse xenograft tumor models.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Trichodermamide B demonstrated potent cytotoxicity against all tested prostate cancer cell lines, with significant inhibition of clonal colony formation in 22Rv1 and PC-3 cells. It also impaired the growth of LNCaP-3D cell spheres, indicating its ability to target both 2D and 3D cancer models. Flow cytometry revealed that trichodermamide B induced cell cycle arrest and apoptosis. Molecular docking studies predicted a strong binding affinity between trichodermamide B and catalase. This was corroborated by experimental data showing that trichodermamide B inhibits the enzymatic activity of catalase in a dose-dependent manner in vitro. This inhibition led to disrupted redox homeostasis, accumulation of reactive oxygen species (ROS), and intense oxidative stress. In AR-dependent LNCaP cells, trichodermamide B suppressed AR activity and downregulated the expression of AR target genes. In vivo studies using zebrafish and mouse xenograft models further validated its anti-prostate cancer efficacy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Trichodermamide B targets catalase while mediating crosstalk between the catalase axis and the AR signalling axis to induce oxidative stress and apoptosis in prostate cancer cells. Its efficacy in both in vitro and in vivo models underscore its viability as a novel drug candidate for prostate cancer treatment.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12964-026-02737-y","type":"journal-article","created":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T08:46:34Z","timestamp":1771231594000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Marine trichodermamide B inhibits prostate cancer progression via catalase inhibition-induced apoptosis"],"prefix":"10.1186","volume":"24","author":[{"given":"Wenxuan","family":"Fang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunmei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingyi","family":"Nie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuyu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianwen","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenghai","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yonghong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuefeng","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueni","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,16]]},"reference":[{"issue":"10398","key":"2737_CR1","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/S0140-6736(23)01055-3","volume":"402","author":"N Agarwal","year":"2023","unstructured":"Agarwal N, Azad AA, Carles J, Fay AP, Matsubara N, Heinrich D, et al. Talazoparib plus enzalutamide in men with first-line metastatic castration-resistant prostate cancer (TALAPRO-2): a randomised, placebo-controlled, phase 3 trial. Lancet. 2023;402(10398):291\u2013303.","journal-title":"Lancet"},{"issue":"53","key":"2737_CR2","doi-asserted-by":"publisher","first-page":"8581","DOI":"10.1038\/sj.onc.1207113","volume":"22","author":"DC Altieri","year":"2003","unstructured":"Altieri DC. Survivin, versatile modulation of cell division and apoptosis in cancer. Oncogene. 2003;22(53):8581\u20139.","journal-title":"Oncogene"},{"issue":"10","key":"2737_CR3","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1016\/S1470-2045(24)00440-6","volume":"25","author":"AA Azad","year":"2024","unstructured":"Azad AA, Bressel M, Tan H, Voskoboynik M, Suder A, Weickhardt AJ, et al. Sequential [(177)Lu]Lu-PSMA-617 and docetaxel versus docetaxel in patients with metastatic hormone-sensitive prostate cancer (UpFrontPSMA): a multicentre, open-label, randomised, phase 2 study. Lancet Oncol. 2024;25(10):1267\u201376.","journal-title":"Lancet Oncol"},{"issue":"1","key":"2737_CR4","doi-asserted-by":"publisher","first-page":"32","DOI":"10.3390\/md21010032","volume":"21","author":"J Cai","year":"2022","unstructured":"Cai J, Wang X, Gan X, Zhou Q, Luo X, Yang B, et al. New chlorinated metabolites and antiproliferative polyketone from the mangrove sediments-derived fungus Mollisia sp. SCSIO41409. Mar Drugs. 2022;21(1):32.","journal-title":"Mar Drugs"},{"key":"2737_CR5","doi-asserted-by":"publisher","first-page":"857041","DOI":"10.3389\/fmicb.2022.857041","volume":"13","author":"J Cai","year":"2022","unstructured":"Cai J, Wang X, Yang Z, Tan Y, Peng B, Liu Y, et al. Thiodiketopiperazines and alkane derivatives produced by the mangrove sediment-derived fungus Penicillium ludwigii SCSIO 41408. Front Microbiol. 2022;13:857041.","journal-title":"Front Microbiol"},{"key":"2737_CR6","doi-asserted-by":"publisher","first-page":"100962","DOI":"10.1016\/j.drup.2023.100962","volume":"68","author":"M Cai","year":"2023","unstructured":"Cai M, Song XL, Li XA, Chen M, Guo J, Yang DH, et al. Current therapy and drug resistance in metastatic castration-resistant prostate cancer. Drug Resist Updat. 2023;68:100962.","journal-title":"Drug Resist Updat"},{"issue":"Pt B","key":"2737_CR7","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.freeradbiomed.2015.05.034","volume":"88","author":"P Canning","year":"2015","unstructured":"Canning P, Sorrell FJ, Bullock AN. Structural basis of Keap1 interactions with Nrf2. Free Radic Biol Med. 2015;88(Pt B):101\u20137.","journal-title":"Free Radic Biol Med"},{"key":"2737_CR8","doi-asserted-by":"publisher","first-page":"102751","DOI":"10.1016\/j.redox.2023.102751","volume":"63","author":"YY Cao","year":"2023","unstructured":"Cao YY, Chen YY, Wang MS, Tong JJ, Xu M, Zhao C, et al. A catalase inhibitor: targeting the NADPH-binding site for castration-resistant prostate cancer therapy. Redox Biol. 2023;63:102751.","journal-title":"Redox Biol"},{"issue":"11","key":"2737_CR9","first-page":"1047","volume":"22","author":"C Chen","year":"2024","unstructured":"Chen C, Wang X, Fang W, Liang J, Cai J, Yang D, et al. Talaketides A-G, linear polyketides with prostate cancer cytotoxic activity from the mangrove sediment-derived fungus Talaromyces sp. SCSIO 41027. Chin J Nat Med. 2024;22(11):1047\u201356.","journal-title":"Chin J Nat Med"},{"issue":"3","key":"2737_CR10","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1038\/s41596-022-00754-y","volume":"18","author":"A Collins","year":"2023","unstructured":"Collins A, M\u00f8ller P, Gajski G, Vodenkov\u00e1 S, Abdulwahed A, Anderson D, et al. Measuring DNA modifications with the comet assay: a compendium of protocols. Nat Protoc. 2023;18(3):929\u201389.","journal-title":"Nat Protoc"},{"issue":"3","key":"2737_CR11","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1210\/endrev\/bnab002","volume":"42","author":"K Desai","year":"2021","unstructured":"Desai K, McManus JM, Sharifi N. Hormonal therapy for prostate cancer. Endocr Rev. 2021;42(3):354\u201373.","journal-title":"Endocr Rev"},{"issue":"1","key":"2737_CR12","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s41240-018-0099-7","volume":"21","author":"Y-S Ding","year":"2018","unstructured":"Ding Y-S, Kim W-S, Park SJ, Kim S-K. Apoptotic effect of physcion isolated from marine fungus Microsporum sp. in PC3 human prostate cancer cells. Fish Aquat Sci. 2018;21(1):22.","journal-title":"Fish Aquat Sci"},{"issue":"5","key":"2737_CR13","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1038\/s41418-022-00988-z","volume":"29","author":"K Engeland","year":"2022","unstructured":"Engeland K. Cell cycle regulation: p53-p21-RB signaling. Cell Death Differ. 2022;29(5):946\u201360.","journal-title":"Cell Death Differ"},{"key":"2737_CR14","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.freeradbiomed.2021.06.010","volume":"172","author":"M Galasso","year":"2021","unstructured":"Galasso M, Gambino S, Romanelli MG, Donadelli M, Scupoli MT. Browsing the oldest antioxidant enzyme: catalase and its multiple regulation in cancer. Free Radic Biol Med. 2021;172:264\u201372.","journal-title":"Free Radic Biol Med"},{"key":"2737_CR15","doi-asserted-by":"publisher","first-page":"113266","DOI":"10.1016\/j.biopha.2022.113266","volume":"152","author":"X Gan","year":"2022","unstructured":"Gan X, Huang H, Wen J, Liu K, Yang Y, Li X, et al. \u03b1-terthienyl induces prostate cancer cell death through inhibiting androgen receptor expression. Biomed Pharmacother. 2022;152:113266.","journal-title":"Biomed Pharmacother"},{"issue":"2","key":"2737_CR16","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1007\/s11010-024-05026-9","volume":"480","author":"X Gan","year":"2024","unstructured":"Gan X, Luo X, Chen J, Fang W, Nie M, Lu H, et al. Ilicicolin C suppresses the progression of prostate cancer by inhibiting PI3K\/AKT\/mTOR pathway. Mol Cell Biochem. 2024;480(2):1089\u2013104.","journal-title":"Mol Cell Biochem"},{"key":"2737_CR17","doi-asserted-by":"publisher","first-page":"175988","DOI":"10.1016\/j.ejphar.2023.175988","volume":"957","author":"X Gan","year":"2023","unstructured":"Gan X, Nie M, Cai S, Liu Y, Zhang F, Feng X, et al. Dankasterone A induces prostate cancer cell death by inducing oxidative stress. Eur J Pharmacol. 2023;957:175988.","journal-title":"Eur J Pharmacol"},{"issue":"6","key":"2737_CR18","doi-asserted-by":"publisher","first-page":"3287","DOI":"10.1172\/JCI132184","volume":"130","author":"A Gjyrezi","year":"2020","unstructured":"Gjyrezi A, Xie F, Voznesensky O, Khanna P, Calagua C, Bai Y, et al. Taxane resistance in prostate cancer is mediated by decreased drug-target engagement. J Clin Invest. 2020;130(6):3287\u201398.","journal-title":"J Clin Invest"},{"key":"2737_CR19","doi-asserted-by":"publisher","first-page":"103404","DOI":"10.1016\/j.redox.2024.103404","volume":"77","author":"C Glorieux","year":"2024","unstructured":"Glorieux C, Buc Calderon P. Targeting catalase in cancer. Redox Biol. 2024;77:103404.","journal-title":"Redox Biol"},{"issue":"10","key":"2737_CR20","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1515\/hsz-2017-0131","volume":"398","author":"C Glorieux","year":"2017","unstructured":"Glorieux C, Calderon PB. Catalase, a remarkable enzyme: targeting the oldest antioxidant enzyme to find a new cancer treatment approach. Biol Chem. 2017;398(10):1095\u2013108.","journal-title":"Biol Chem"},{"issue":"10","key":"2737_CR21","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.1016\/j.bcp.2011.06.007","volume":"82","author":"C Glorieux","year":"2011","unstructured":"Glorieux C, Dejeans N, Sid B, Beck R, Calderon PB, Verrax J. Catalase overexpression in mammary cancer cells leads to a less aggressive phenotype and an altered response to chemotherapy. Biochem Pharmacol. 2011;82(10):1384\u201390.","journal-title":"Biochem Pharmacol"},{"key":"2737_CR22","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.intimp.2017.03.003","volume":"46","author":"X Gong","year":"2017","unstructured":"Gong X, Yang Y, Huang L, Zhang Q, Wan RZ, Zhang P, et al. Antioxidation, anti-inflammation and anti-apoptosis by paeonol in LPS\/d-GalN-induced acute liver failure in mice. Int Immunopharmacol. 2017;46:124\u201332.","journal-title":"Int Immunopharmacol"},{"issue":"14","key":"2737_CR23","doi-asserted-by":"publisher","first-page":"3870","DOI":"10.1158\/0008-5472.CAN-13-3440","volume":"74","author":"L Gopinathan","year":"2014","unstructured":"Gopinathan L, Tan SL, Padmakumar VC, Coppola V, Tessarollo L, Kaldis P. Loss of Cdk2 and cyclin A2 impairs cell proliferation and tumorigenesis. Cancer Res. 2014;74(14):3870\u20139.","journal-title":"Cancer Res"},{"issue":"2","key":"2737_CR24","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.ccell.2020.06.001","volume":"38","author":"JD Hayes","year":"2020","unstructured":"Hayes JD, Dinkova-Kostova AT, Tew KD. Oxidative stress in cancer. Cancer Cell. 2020;38(2):167\u201397.","journal-title":"Cancer Cell"},{"issue":"6","key":"2737_CR25","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1038\/nrm3801","volume":"15","author":"KM Holmstr\u00f6m","year":"2014","unstructured":"Holmstr\u00f6m KM, Finkel T. Cellular mechanisms and physiological consequences of redox-dependent signalling. Nat Rev Mol Cell Biol. 2014;15(6):411\u201321.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"4","key":"2737_CR26","doi-asserted-by":"publisher","first-page":"e202400070","DOI":"10.1002\/cbdv.202400070","volume":"21","author":"L Huang","year":"2024","unstructured":"Huang L, Chen C, Cai J, Chen Y, Zhu Y, Yang B, et al. Discovery of enzyme inhibitors from Mangrove sediment derived Fungus Trichoderma harzianum SCSIO 41051. Chem Biodivers. 2024;21(4):e202400070.","journal-title":"Chem Biodivers"},{"issue":"4","key":"2737_CR27","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1111\/cas.13517","volume":"109","author":"H Ide","year":"2018","unstructured":"Ide H, Lu Y, Noguchi T, Muto S, Okada H, Kawato S, et al. Modulation of AKR1C2 by curcumin decreases testosterone production in prostate cancer. Cancer Sci. 2018;109(4):1230\u20138.","journal-title":"Cancer Sci"},{"issue":"20","key":"2737_CR28","doi-asserted-by":"publisher","first-page":"7610","DOI":"10.1158\/0008-5472.CAN-04-1608","volume":"64","author":"Q Ji","year":"2004","unstructured":"Ji Q, Aoyama C, Nien YD, Liu PI, Chen PK, Chang L, et al. Selective loss of AKR1C1 and AKR1C2 in breast cancer and their potential effect on progesterone signaling. Cancer Res. 2004;64(20):7610\u20137.","journal-title":"Cancer Res"},{"key":"2737_CR29","doi-asserted-by":"publisher","first-page":"156463","DOI":"10.1016\/j.phymed.2025.156463","volume":"139","author":"B Jia","year":"2025","unstructured":"Jia B, Zhang M, Jiang X, Zhou S, Han K, Deng R, et al. 6-C-methylquercetin in Baeckea frutescens exerts anti-prostate cancer effect via ErbB\/PI3K\/AKT pathway. Phytomedicine. 2025;139:156463.","journal-title":"Phytomedicine"},{"key":"2737_CR30","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1146\/annurev-immunol-073119-095439","volume":"38","author":"S Kesavardhana","year":"2020","unstructured":"Kesavardhana S, Malireddi RKS, Kanneganti TD. Caspases in cell death, inflammation, and pyroptosis. Annu Rev Immunol. 2020;38:567\u201395.","journal-title":"Annu Rev Immunol"},{"issue":"6","key":"2737_CR31","doi-asserted-by":"publisher","first-page":"1949","DOI":"10.1523\/JNEUROSCI.21-06-01949.2001","volume":"21","author":"RA Kirkland","year":"2001","unstructured":"Kirkland RA, Franklin JL. Evidence for redox regulation of cytochrome C release during programmed neuronal death: antioxidant effects of protein synthesis and caspase inhibition. J Neurosci. 2001;21(6):1949\u201363.","journal-title":"J Neurosci"},{"issue":"3","key":"2737_CR32","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1208\/s12248-011-9279-4","volume":"13","author":"S Mahapatra","year":"2011","unstructured":"Mahapatra S, Karnes RJ, Holmes MW, Young CY, Cheville JC, Kohli M, et al. Novel molecular targets of Azadirachta indica associated with inhibition of tumor growth in prostate cancer. AAPS J. 2011;13(3):365\u201377.","journal-title":"AAPS J"},{"issue":"2","key":"2737_CR33","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.3390\/ijms24021435","volume":"24","author":"E Montuori","year":"2023","unstructured":"Montuori E, Hyde CAC, Crea F, Golding J, Lauritano C. Marine natural products with activities against prostate cancer: recent discoveries. Int J Mol Sci. 2023;24(2):1435.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"2737_CR34","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1007\/s11033-024-09917-4","volume":"51","author":"M Nie","year":"2024","unstructured":"Nie M, Li T, Liu P, Wang X. Therapeutic potential of targeting AKR1C2 in the treatment of prostate cancer. Mol Biol Rep. 2024;51(1):994.","journal-title":"Mol Biol Rep"},{"key":"2737_CR35","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/S0009-2797(02)00179-5","volume":"143\u2013144","author":"TL Rizner","year":"2003","unstructured":"Rizner TL, Lin HK, Penning TM. Role of human type 3 3alpha-hydroxysteroid dehydrogenase (AKR1C2) in androgen metabolism of prostate cancer cells. Chem Biol Interact. 2003;143\u2013144:401\u20139.","journal-title":"Chem Biol Interact"},{"issue":"4","key":"2737_CR36","first-page":"676","volume":"3","author":"Y Sekino","year":"2020","unstructured":"Sekino Y, Teishima J. Molecular mechanisms of docetaxel resistance in prostate cancer. Cancer Drug Resist. 2020;3(4):676\u201385.","journal-title":"Cancer Drug Resist"},{"issue":"6","key":"2737_CR37","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.3390\/molecules27061823","volume":"27","author":"S Shao","year":"2022","unstructured":"Shao S, Wang X, She J, Zhang H, Pang X, Lin X, et al. Diversified chaetoglobosins from the marine-derived fungus Emericellopsis sp. SCSIO41202. Molecules. 2022;27(6):1823.","journal-title":"Molecules"},{"key":"2737_CR38","doi-asserted-by":"publisher","first-page":"101084","DOI":"10.1016\/j.redox.2018.101084","volume":"25","author":"US Srinivas","year":"2019","unstructured":"Srinivas US, Tan BWQ, Vellayappan BA, Jeyasekharan AD. ROS and the DNA damage response in cancer. Redox Biol. 2019;25:101084.","journal-title":"Redox Biol"},{"issue":"4","key":"2737_CR39","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1210\/jc.2007-2708","volume":"93","author":"AZ Steiner","year":"2008","unstructured":"Steiner AZ, Chang L, Ji Q, Ookhtens M, Stolz A, Paulson RJ, et al. 3alpha-Hydroxysteroid dehydrogenase type III deficiency: a novel mechanism for hirsutism. J Clin Endocrinol Metab. 2008;93(4):1298\u2013303.","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2737_CR40","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1038\/aps.2016.139","volume":"38","author":"JY Sun","year":"2017","unstructured":"Sun JY, Wang JD, Wang X, Liu HC, Zhang MM, Liu YC, et al. Marine-derived chromopeptide A, a novel class I HDAC inhibitor, suppresses human prostate cancer cell proliferation and migration. Acta Pharmacol Sin. 2017;38(4):551\u201360.","journal-title":"Acta Pharmacol Sin"},{"issue":"7","key":"2737_CR41","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1038\/nrd2803","volume":"8","author":"D Trachootham","year":"2009","unstructured":"Trachootham D, Alexandre J, Huang P. Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach? Nat Rev Drug Discov. 2009;8(7):579\u201391.","journal-title":"Nat Rev Drug Discov"},{"issue":"6","key":"2737_CR42","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1007\/s00204-023-03476-6","volume":"97","author":"B Wang","year":"2023","unstructured":"Wang B, Wang Y, Zhang J, Hu C, Jiang J, Li Y, et al. ROS-induced lipid peroxidation modulates cell death outcome: mechanisms behind apoptosis, autophagy, and ferroptosis. Arch Toxicol. 2023;97(6):1439\u201351.","journal-title":"Arch Toxicol"},{"issue":"52","key":"2737_CR43","doi-asserted-by":"publisher","first-page":"38697","DOI":"10.1039\/D4RA06292B","volume":"14","author":"J Wang","year":"2024","unstructured":"Wang J, Lu H, Fang W, Lin M, Feng Y, Qi X, et al. Antiproliferative effects of resorcylic acid lactones from the Beibu Gulf coral-derived fungus Curvularia lunata GXIMD 02512 on prostate cancer cells. RSC Adv. 2024;14(52):38697\u2013705.","journal-title":"RSC Adv"},{"key":"2737_CR44","doi-asserted-by":"publisher","first-page":"920554","DOI":"10.3389\/fphar.2022.920554","volume":"13","author":"X Wang","year":"2022","unstructured":"Wang X, Luo X, Gan X, Chen C, Yang Z, Wen J, et al. Analysis of regulating activities of 5\u2019-epiequisetin on proliferation, apoptosis, and migration of prostate cancer cells in vitro and in vivo. Front Pharmacol. 2022;13:920554.","journal-title":"Front Pharmacol"},{"issue":"23","key":"2737_CR45","doi-asserted-by":"publisher","first-page":"5001","DOI":"10.1158\/0008-5472.CAN-15-0563","volume":"75","author":"X Wang","year":"2015","unstructured":"Wang X, Simpson ER, Brown KA. p53: protection against tumor growth beyond effects on cell cycle and apoptosis. Cancer Res. 2015;75(23):5001\u20137.","journal-title":"Cancer Res"},{"key":"2737_CR46","doi-asserted-by":"publisher","first-page":"174251","DOI":"10.1016\/j.ejphar.2021.174251","volume":"907","author":"X Wang","year":"2021","unstructured":"Wang X, Zhu J, Yan H, Shi M, Zheng Q, Wang Y, et al. Kaempferol inhibits benign prostatic hyperplasia by resisting the action of androgen. Eur J Pharmacol. 2021;907:174251.","journal-title":"Eur J Pharmacol"},{"issue":"3","key":"2737_CR47","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1038\/s43018-024-00738-9","volume":"5","author":"K Wu","year":"2024","unstructured":"Wu K, El Zowalaty AE, Sayin VI, Papagiannakopoulos T. The pleiotropic functions of reactive oxygen species in cancer. Nat Cancer. 2024;5(3):384\u201399.","journal-title":"Nat Cancer"},{"issue":"5","key":"2737_CR48","doi-asserted-by":"publisher","first-page":"218","DOI":"10.3390\/md22050218","volume":"22","author":"B Yang","year":"2024","unstructured":"Yang B, Shao S, Nie M, Tie Q, Pang X, Lin X, et al. Novel metabolites from the marine-derived fungus Peniophora sp. SCSIO41203 show promising in vitro antitumor activity as methuosis inducers in PC-3 cells. Mar Drugs. 2024;22(5):218.","journal-title":"Mar Drugs"},{"issue":"6","key":"2737_CR49","doi-asserted-by":"publisher","first-page":"4607","DOI":"10.1007\/s11033-022-07307-2","volume":"49","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, Chen J, Fang W, Liang K, Li X, Zhang F, et al. Kaempferol suppresses androgen-dependent and androgen-independent prostate cancer by regulating Ki67 expression. Mol Biol Rep. 2022;49(6):4607\u201317.","journal-title":"Mol Biol Rep"}],"container-title":["Cell Communication and Signaling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12964-026-02737-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12964-026-02737-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12964-026-02737-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T18:18:42Z","timestamp":1781633922000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12964-026-02737-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,16]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2737"],"URL":"https:\/\/doi.org\/10.1186\/s12964-026-02737-y","relation":{},"ISSN":["1478-811X"],"issn-type":[{"value":"1478-811X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,16]]},"assertion":[{"value":"15 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Institutional Animal Welfare and Ethical Committee of Guangxi University of Chinese Medicine (approval code: DW20230525-090\u201305, DW20241025-02).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"192"}}